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Abstract
Background: The appropriateness and cost-effectiveness of screening mammography (SM) for women younger
than 50 and older than 74 years is debated in the clinical research community, among health care providers, and
by the American public. This study explored primary care physicians’ (PCPs) perceptions of the influence of clinical
practice guidelines for SM; the recommendations for SM in response to hypothetical case scenarios; and the factors
associated with perceived SM effectiveness and recommendations in the US from June to December 2009 before
the United States Preventive Services Task Force (USPSTF) recently revised guidelines.
Methods: A nationally representative sample of 11,922 PCPs was surveyed using a web-based questionnaire.
The response rate was 5.7% (684); (41%) 271 family physicians (FP), (36%) 232 general internal medicine
physicians (IM), (23%) 150 obstetrician-gynaecologists (OBG), and (0.2%) 31 others. Cross-sectional analysis
examined PCPs perceived effectiveness of SM, and recommendation for SM in response to hypothetical case
scenarios. PCPs responses were measured using 4-5 point adjectival scales. Differences in perceived effectiveness
and recommendations for SM were examined after adjusting for PCPs specialty, race/ethnicity, and the US
region.
Results: Compared to IM and FP, OBG considered SM more effective in reducing breast cancer mortality among
women aged 40-49 years (p = 0.003). Physicians consistently recommended mammography to women aged 50-69
years with no differences by specialty (p = 0.11). However, 94% of OBG “always recommended” SM to younger and
86% of older women compared to 81% and 67% for IM and 84% and 59% for FP respectively (p=< .001). In
ordinal regression analysis, OBG specialty was a significant predictor for perceived higher SM effectiveness and
recommendations for younger and older women. In evaluating hypothetical scenarios, overall PCPs would
recommend SM for the 80 year woman with CHF with a significant variation by specialty (38% of OBG, 18% of FP,
17% of IM; p = < .001).
Conclusions: A majority of physicians, especially OBG, favour aggressive breast cancer screening for women from
40 through 79 years of age, including women with short life expectancy. Policy interventions should focus on
educating providers to provide tailored recommendations for mammography based on individualized cancer risk,
health status, and preferences.
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Screening mammography every one to two years for
women aged 50 to 69 years has resulted in earlier breast
cancer detection, and reduced breast cancer mortality
[1,2]. The value of screening mammography for this age
group is widely accepted. However, the appropriateness
and cost-effectiveness of screening mammography in
women younger than 50 and older than 74 years of age
is not fully established, leading professional societies to
issue conflicting recommendations [3].
The United States Preventive Services Task Force
(USPSTF) recommends against routine screening mam-
mography for average-risk younger (ages 40 to 49)
women, in favour of “individualized, informed decision
making about when to begin screening mammography”
and suggests that biennial mammography be encouraged
from ages 50-74 [4]. The American Cancer Society
(ACS) differs slightly, providing no specific age for stop-
ping and stating that comorbidity is the only qualifying
factor for exclusion from screening. The American Col-
lege of Obstetricians and Gynaecologists (ACOG) [5]
recommends mammography every one to two years in
women from 40 to 50 years of age and annually after
age 50 with no specific age for stopping. The American
Geriatrics Society recommends mammography for older
women unless they are unlikely to survive 5 years or
have significant comorbidities that would preclude
breast cancer treatment [6,7].
Primary care physicians (PCPs) play a critical role in
recommending age-appropriate cancer screening to eli-
gible patients, and their acceptance of practice guide-
lines is essential in translating recommendations into
improved health outcomes. However, when practice
guidelines are unclear, physicians and patients can
become confused [8,9]. Lack of consensus on screening
mammography guidelines for younger and older women
allows physicians to come to different conclusions
regarding when to use mammography [10]. Such uncer-
tainties can lead to underuse of cancer screening in
healthy older women with substantial life expectancies,
and overuse of cancer screening in women with severe
comorbidities and limited life expectancies.
Previous studies have identified physician characteris-
tics, including specialty, age, and gender that are asso-
ciated with the use of screening mammography [11,12].
For example, OBG are more likely to recommend mam-
mography to women 40-49 years of age than general
internists and family physicians [13]. However, it is not
well understood whether this variation in physician
practices is related to variation in clinical practice guide-
lines, and the influence of those guidelines on primary
care physicians of three primary care specialty. The
objectives of this study were to explore (1) US primary
care physicians’ beliefs about the effectiveness of screen-
ing mammography before the revised USPSTF guide-
lines in 2009; (2) their decisions regarding screening
mammography in hypothetical clinical case scenarios;
and (3) predictors of effectiveness and recommendations
for screening mammography in different age categories.
We hypothesized that physicians’ recommendations for
screening mammography for younger and older women
are related to their demographic and practice character-
istics (particularly specialty,a sp r e v i o u s l yd o c u m e n t e d ) ,
but also to their beliefs about the effectiveness of mam-
mography, and influence of published practice
guidelines.
Methods
Study design
We surveyed a nationally representative sample of
11,922 PCPs (general internists, family physicians, and
obstetricians and gynecologists) in the US between June,
2009 and December, 2009. The sample of physicians
was obtained from the American Medical Association’s
[14] Physician Masterfile [11,13]. A random sample of
primary care physicians were invited to participate in a
web based questionnaire on screening mammography
practices from June 2009 to December 2009. Eligible
respondents included physicians younger than 76 years
of age, who held an active license to practice medicine,
and listed patient care as their primary professional
activity. We excluded physicians over 75 years of age,
and physicians who were not engaged in patient care.
Survey instrument
The questionnaire was composed of three parts: (a) 6
single item questions about knowledge and beliefs
regarding screening mammography and recommenda-
tions in community practice, (b) 8 questions about deci-
sion-making for mammography in specific clinical
situations, and (c) 16 single item questions on personal
background and practice characteristics. The questions
in part a of the questionnaire used four-point adjectival
scales that included the response categories “not effec-
tive”, “somewhat effective”, “very effective”,a n d“not
sure.” The perceived influence of USPSTF guidelines on
physicians practice was measured using the response
categories “not influenced”, “somewhat influenced”,
“extremely influenced”,a n d“not familiar with this
guideline.” Additional questions described asympto-
matic, average risk women in 3 different age categories
[40-49 y, 50-69 y, 70-89 y], and asked respondents
about their usual advice on starting age and stopping
age, for which professional guidelines are unclear or
conflicting. “Conflicting” guidelines were defined as dif-
ferent screening mammography recommendations from
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included “never recommend,”“ rarely recommend”,
“sometimes recommend”, “often recommend,” and
“always recommend,” as appropriate. Written case simu-
lations (vignettes) in part b were designed on the basis
of a fractional factorial design that ensures the absence
of collinearity. For the clinical vignettes (case scenarios),
the dependent variable was the physician’s decision to
recommend mammography or not, and the independent
variables were age (young and old), health status
(comorbidities present/absent), and severity and comor-
bidity burden (associated within life expectancies of < 5
and > = 5 years). Screening mammography decision-
making was assessed by asking physicians whether they
would recommend or not recommend screening mam-
mography for each hypothetical case; physicians
responded “definitely would not recommend,”“ probably
would not recommend,”“ probably would recommend,”
or “definitely would recommend.”
The questionnaire items and the format were pilot
tested for clarity and face validity in two different set-
tings, including primary care physician participants in a
health services research seminar at UC Davis and a web
based questionnaire e-mailed to primary care colleagues
in academic settings.
Sampling methodology
Using the American Medical Association’s( A M A )P h y -
sician Masterfile as the sampling frame, we aimed to
survey a nationally representative sample of primary
care physicians [15] from June 2009 though December
2009. The AMA Masterfile contains demographic and
practice-related data on virtually all allopathic and
osteopathic physicians in the United States. Obstetri-
cians/gynaecologists (OBG) were included in the sample
because they provide preventive services for many
women in the United States [16,17]. We asked the
AMA to provide overall counts of primary care physi-
cians with accessible email addresses and counts of
PCPs with no email addresses, for 3 primary care spe-
cialties in the 4 US regions. A total of 261721 PCPs
were identified in the database and email addresses were
available for (44.7%) 119747. Of those (40.4%) 48378
were family physicians, (43.6%) 52199 general internists,
and (16%) 19170 obstetricians/gynaecologists. The sam-
pling frame was stratified by physician specialty (IM, FP
and OBG) and years in practice (1-9, 10-20 and > 20).
Systematic random sampling was performed after sort-
ing the sampling frame by U.S. Census region (North-
east, Midwest, South, and West) to ensure adequate
representation of primary care physicians in each Cen-
sus region (Northeast, Midwest, South, and West). OBG
and the US regions where < = 30% physicians were
accessible by email were oversampled at a rate of
approximately 2.5 to achieve appropriate representation
of physicians by specialty (IM, FP and OBG) in all
regions. The probability of selection for physicians in
each specialty was proportional to the specialty’sr e p r e -
s e n t a t i o ni nt h eU . S .p h y s i c i an population. Population
counts and sample specifications were provided to the
AMA. Sample variables requested from the AMA are
displayed in (Table 1).
Anticipating a 10% response rate we estimated that a
total of 11,922 would be sufficient to provide 80%
power to find a 10% difference between physician spe-
cialties including family physicians, general internists
and obstetricians/gynaecologists. Accordingly primary
care physicians were emailed a Broadcast letter from the
AMA describing the objectives of the survey, with a link
to a secure Internet website. Instructions were provided
on how to complete the survey if the respondent chose
to open the link to the survey. The survey took approxi-
mately 15 minutes to complete. The cover letter stressed
the importance of breast cancer screening recommenda-
tions and comorbidities to the nation’s public health. A
financial incentive of $5 for the first round was subse-
quently increased to $ 20 in follow-up rounds to
improve the response rate. The study was approved by
the Institutional Review Board of the University of Cali-
fornia, Davis.
Statistical methods
Demographic characteristics, practice characteristics,
and responses to questionnaire items were examined by
physician specialty. Differences in response distributions
between physician specialties were considered statisti-
cally significant at the p < 0.05 level. We tested the sta-
tistical significance of differences between ratings across
specialties using analysis of variance.
We tested bivariate associations between the indepen-
dent variables and outcomes including; physicians per-
ceived screening mammography effectiveness in
decreasing mortality from breast cancer, influence of
guidelines, and screening mammography recommenda-
tions for women in 3 age groups using ANOVA for
categorical variables. We then performed ordinal logistic
regression to analyze the association of response scores
at 1 level increase in the odds ratios for each outcome
of interest) with significant physician and practice char-
acteristics. For physician’s beliefs regarding perceived
effectiveness, the outcome variable was scored 1 for “not
effective”,2f o r“somewhat effective”,a n d3f o r“very
effective": respondents who said, “not sure” were
excluded due to small numbers. To analyze the influ-
ence of USPSTF guideline on physicians practice, the
outcome variable was scored 1 for “not influenced”,2
for “somewhat influenced”,a n d3f o r“extremely influ-
enced"; respondents who said, “not familiar with
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analyze screening mammography recommendations, we
compared “always” and “often” to “sometimes”, “rarely”,
and “never” for 40-49 and 70-80 years old women. For
50-69 years old women, we compared “always” to
“often”, “sometimes”, rarely”, and “never” because no IM
physician answered “often”. The rates for missing values
were less than 5% for item specific response and were
excluded from the analysis.
After accounting for undeliverable emails, we com-
pared physicians who responded later in the survey
administration period, after the second and third Med
Table 1 Responding primary care physicians’ demographic and practice characteristics
Primary care specialty Family Physicians General Internal Medicine Obstetrics and gynaecology
FP IM OBG Total
n = 271 (41.5%) n = 232 (35.5%) n = 150 (23.0%) n = 653 P- value
Race/Ethnicity
White 213 (79) 164 (71) 120 (81) 497 (76) 0.002
AA 8 (3) 12 (5) 4 (3) 24 (4)
Hispanic 15 (6) 2 (1) 3 (2) 20 (3)
Asian 30 (11) 51 (22) 21 (14) 102 (16)
Other 5 (2) 3 (1) 1 (1) 9 (1)
Gender
Male 161 (59) 136 (59) 71 (47) 368 (56) 0.04
Female 110 (41) 96 (41) 79 (53) 285 (44)
Age in years
25-44 103 (38) 93 (40) 48 (32) 244 (37) 0.403
45-54 82 (30) 71 (31) 53 (36) 206 (32)
55-64 71 (26) 58 (25) 36 (24) 165 (25)
65 + 15 (6) 10 (4) 12 (8) 37 (6)
Number of years in practice
1~9 yrs 106 (39) 92 (40) 56 (37) 254 (39) 0.57
10~20 yrs 103 (38) 80 (34) 49 (33) 232 (36)
> = 21 yrs 62 (23) 60 (26) 45 (30) 167 (26)
US Region
North East 52 (19) 76 (33) 39 (26) 167 (26) < 0.001
Mid West 67 (25) 55 (24) 19 (13) 141 (22)
South 63 (23) 58 (25) 38 (25) 159 (24)
West 89 (33) 43 (19) 54 (36) 186 (28)
Percent of female patients seen per week (mean)
New patients 21% 25% 37% 26% < 0.001
Had a mammogram (Female physicians only) n = 238
Yes 77 (71) 68 (72) 58 (73) 203 (72)
No 32 (29) 27 (28) 21 (27) 80 (28)
Personal History of breast cancer (Female physicians only) n = 282
Yes 7 (6) 3 (3) 0 (0) 10 (4)
No 103 (94) 92 (97) 77 (100) 272 (96)
Family History of breast cancer n = 472
Yes 60 (30) 58 (37) 45 (38) 163 (35)
No 137 (70) 99 (63) 73 (62) 309 (65)
Percent of time spent week *
Mean SD Mean SD Mean SD Mean SD
Patient care 83 23 78 26 79 21 80 24
Teaching/research 10 16 15 20 12 16 12 17
Administration 13 15 14 17 13 13 13 15
Other 2 6 6 16 3 13 4 12
P is significant for < 0.05.
* Data are presented as mean and standard deviation.
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who responded to the first Med E-Mail Broadcast and
lower incentives, to explore the potential for response
bias. Previous studies suggest that late or marginal
respondents to a survey are often similar to non-respon-
dents, in comparison with early respondents [18-20].
Differences in demographic and practice characteristics
between early and late respondents, and their associa-
tion with mammography practices and recommenda-
tions, were examined. No information was available
about nonrespondents.
Results
Of the 11, 922 physicians invited to complete a web-
based questionnaire, 11103 (93%) were delivered, and
11% were undelivered. Of the 11,103 only (2%) 227
opened the survey at first e-mail broadcast and 1% com-
pleted the survey. In three subsequent e-mail broadcasts
when the incentive was increased to $ 20, the cumula-
tive response rate increased to 7% with 2% click through
and 5% completing the survey. The initial survey was
emailed in June 2009, and the survey was closed in
December 2009.
A total of 684 physicians completed the survey, of
whom 271 (41%) were family physicians (FP), 232 (36%)
were general internal medicine physicians (IM), 150
(23%) were obstetrician-gynaecologists (OBG), and 31
did not practice primary care and were eliminated from
further analysis. Overall respondents were predomi-
nantly white (76%), male (56%) and 79% provided
patient care. Physicians’ age, number of years in prac-
tice, and the percent of female patients seen in a typical
week did not vary by primary care specialty (Table 1).
Description of respondents and perceived effectiveness of
screening mammography
The proportion of family physicians and internal medi-
cine who believed that screening mammography is very
effective in reducing breast cancer mortality was 44%
for women aged 40-49 years, 87% for women 50-69
years, and 42% for women 70-79 years of age (Figure 1).
However, obstetricians and gynaecologists indicated
stronger belief in the effectiveness of screening mammo-
graphy in reducing breast cancer mortality by 61% in
younger (40-49 year old) and 56% older (70 years or
over) women.
Physician’s age, gender, years in practice, personal or
family history of breast cancer were not associated with
perceived mammography effectiveness for women across
all age categories.
Influence of published USPSTF guidelines and screening
mammography recommendations by patient’s age and
health status
Overall 45% of respondents rated the U.S. Preventive
Services Task Force (USPSTF) guidelines as “extremely
influential,” but endorsement of this statement was
higher among FP (53%) and IM (47%) than among OBG
(25%) (P=< .001 for both comparisons). In comparison
with FP and IM, OBG were more likely to describe
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can College of Obstetricians and Gynaecologists guide-
lines (ACOG) (p = < 0.001) to be “very influential” on
their practice.
Greater than 95% of respondents indicated that they
(often and always responses were combined: “always”)
“always” recommend screening mammography to aver-
age risk women aged 50-69 years, with no differences by
physician specialty (p = 0.11). However, OBG differed
from IM and FP in their recommendations for younger
women: 94% of OBG “always” recommended mammo-
graphy to women 40-49 years versus 81% of IM and
84% of FP (p=< .001 for both comparisons). Similarly,
a significantly higher proportion of OBG (86%) indicated
“always” recommending screening mammography to
older women (aged 70-89 years), compared to 67% for
IM and 59% for FP (p=<. 0 0 1f o rb o t hc o m p a r i s o n s ) .
None of these differences between IM and FP was sta-
tistically significant (Figure 2).
Physicians’ clinical decision-making regarding recom-
mending a screening mammogram (yes/no) for hypothe-
tical case vignettes showed that overall 37% of
physicians would recommend mammography for a 50
year old woman with unresectable non-small cell lung
cancer, and 21% for an 80 year old woman with conges-
tive heart failure from ischemic cardiomyopathy who
has dyspnoea with ordinary activities. However, OBG
(37%) differed significantly from IM (17%) and FP (16%)
in recommending mammography in hypothetical case-
situations with limited life expectancies of < 5 years (p
=<0 . 0 0 1 ). There were no significant differences across
physician specialties regarding mammography recom-
mendations for asymptomatic 55 and 70 year old
women (Table 2).
Bivariate analysis showed that physicians beliefs of
screening mammography in reducing breast cancer mor-
tality for women aged 40-49 years were not associated
with physicians gender, age, number of years in practice,
family history of breast cancer or personal history of
breast cancer among female physicians. However, the
mean scores for response “very effective” were signifi-
cantly higher for physicians of Asian race/ethnicity (p =
< 0.01), those practicing in the South regions of the US
(p = 0.05), and female physicians who had a mammo-
gram (p = 0.03) (Additional File 1, Table S1).
The results of multivariate models (ordinal logistic
regression analysis, and logistic regression) adjusted for
primary care specialty, physician’s race/ethnicity, and
the US region are displayed in Table 3. OBG compared
to FP had significantly higher odds for perceived effec-
tiveness of mammography among women aged 40-49
and 70-89 years (OR 2.0, 95% CI: 1.3-3.1 and 4.4, 95%
CI: 2.6-7.8, respectively). OBG were also more likely
than FP to recommend mammography for women ages
40-49 (OR 3.0, 95% CI: 1.4-6.3), 50-69 years (OR 2.5,
95% CI: 1.1-5.9) and for older women age 70 or over
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Figure 2 Primary care physicians’ recommendations for screening mammography. How often do you recommend screening
mammography for average-risk women?
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did not differ significantly from family physicians in
their ratings of the perceived effectiveness of mammo-
graphy, and their recommendations for screening
mammography.
There were no differences in demographic and prac-
tice characteristics of physicians who responded to the
first and second Med E-Mail Broadcast. Physicians who
responded to third Med E-Mail Broadcast (third-wave
respondents) compared to earlier respondents showed
significant differences by demographic and practice
characteristics. Early respondents (first and second
wave) compared to third-wave respondents were more
likely to be females compared to males (58% versus
44%) (p = < 0.001); 25-54 of age compared those age >
= 55 years (84% versus 69%), OBG compared to FP
(34% versus 23%), those reporting higher percent of new
females patients seen per week (27% versus 26%) and
physicians who were < = 9 years in practice (48% versus
38%) P = < 0.001. However, there were no differences in
responses between early compared to late respondents
in the physician’s perceived belief in mammography
effectiveness in reducing breast cancer mortality,
responses to guideline influence, and recommendations
for screening for women in different age categories.
Discussion
In this cross sectional survey, the majority of PCPs
believed in the effectiveness of mammography in redu-
cing breast cancer mortality for women between 50 and
69 years of age, consistent with screening mammogra-
phy consensus guidelines. However, we observed incon-
sistency between guideline influence and screening
practices and recommendations. Despite higher endorse-
ment of USPSTF guidelines by FP and IM than other
guidelines, 84% of family physicians, 81% of internists
reported recommending mammography to women aged
40-49 years. Overall, 15% of physicians would recom-
mend mammography to a 50 year old woman with
unresectable lung cancer and an 80 year old woman
with advanced heart failure.
In comparisons across physician specialties, OBG indi-
cated stronger belief in the effectiveness of mammogra-
phy in reducing breast cancer mortality, and were more
likely to recommend mammography, in younger (40-49
year old) and older (70 years or over) women (Figure 2).
Table 2 Primary care physicians’ responses to clinical vignettes by primary care specialty
Primary care
specialty
Family
Physicians
General Internal
Medicine
Obstetrics and
gynaecology
FP IM OBG* Over
all
IM vs
OBG
FP vs
OBG
FP vs
IM
Would order screening mammogram for following
case scenarios.......
n (%) n (%) n (%) P- value
Healthy 70 year old woman 245 (90) 223 (96) 143 (95) 0.024 0.795 0.088 0.013
50-year-old with unresectable non-small cell lung
cancer
102 (38) 61 (26) 81 (54) <
0.001*
<
0.001*
0.001* 0.007
Healthy 55-year-old woman 264 (97) 224 (97) 148 (99) 0.466 0.327 0.501 0.608
80-year-old with ischemic cardiomyopathy who has
dyspnoea with ordinary activity
44 (16) 39 (17) 56 (37) <
0.001*
<
0.001*
<
0.001*
0.904
All P values are two sided. * OBG compared to FP were significantly (P < 0.001).
Table 3 Primary care physicians’ perceived effectiveness,
and recommendations of screening mammography for
average-risk women
Model 1* Model 2
†
Perceived effectiveness (Ordinal logistic regression)
1. “not effective”,2 .“somewhat effective”,3 .“very effective”
Age 40-49 years
IM vs FP 1.06 (0.8-1.5) 0.9 (0.7-1.3)
OBG vs FP 1.98 (1.3-3.0) 2.0 (1.3-3.1)
Age 50-69 years
IM vs FP 1.0 (0.6-1.7) 1.0 (0.6-1.7)
OBG vs FP 1.0 (0.6-1.9) 1.1 (0.6-2.7)
Age 70-89 years
IM vs FP 1.4 (0.9-2.0) 1.3 (0.9-1.9)
OBG vs FP 4.3 (2.5-7.3) 4.5 (2.6-7.8)
Recommendations for screening mammography (Logistic
regression)
Age 40-49 years: “always"/"often” vs “sometime"/"rarely"/"never”
IM vs FP 0.8 (0.5-1.3) 0.7 (0.5-1.2)
OBG vs FP 2.9 (1.4-6.2) 3.0 (1.4-6.3)
Age 50-69 years: “always” vs “often"/"sometime"/"rarely"/"never”
IM vs FP 1.0 (0.6-1.7) 1.1 (0.6-1.9)
OBG vs FP 2.4 (1.04-5.7) 2.5 (1.1-5.9)
Age 70-89: “always"/"often” vs “sometime"/"rarely"/"never”
IM vs FP 1.4 (0.9-1.2) 1.3 (0.9-1.9)
OBG vs FP 4. 3 (2.5-7.4) 4.5 (2.6-1.9)
*Model 1. Primary care physician specialty; comparing general internists and
obstetricians and gynaecologists versus reference category family physicians.
† Model 2. Adjusted for primary care physician specialty (reference category:
FP), US region (reference category: Northeast), and race/ethnicity (reference
category: white).
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screening may reflect ACS and ACOG guidelines, which
recommend mammography every one to two years in
women from 40 to 50 years of age and annually after
age 50 with no specific age for cessation [5].
The association between stronger beliefs and recom-
mendations for screening mammography by OBG com-
pared to IM and FP in this study are in agreement with
previous studies [17,20].
Discordance between endorsement of guidelines and
actual practice has been observed in previous studies
[2,21]. A possible explanation for this finding is that
mammography for women aged 40-49 years is consid-
ered the standard of care in community practice and
community physicians do not routinely act upon pub-
lished guidelines in spite of their confidence in the
guideline [2,21,22]. Clinicians may not fully appreciate
that guidelines acknowledge the limited benefits of
mammography in women aged 40-49 and > = 75 years
and recommend that women at an average risk for
breast cancer should make an informed decision with
health care providers for breast cancer screening options
based on patient preferences, health status and life
expectancy.
This survey took place from June 2009 to December
2009. We observed differences in screening mammogra-
phy recommendations between specialties before the
release of the USPSTF update on breast cancer screen-
ing in November 2009 [4]. It is unclear how the revised
USPSTF guidelines, which provoked considerable debate
in the media, may have affected these differences. To
the extent that USPSTF guidelines have more influence
on the mammography recommendations of family phy-
sicians and general internists, compared with OBG, the
observed differences in perceived effectiveness and
recommendations for women aged 40-49 years in Table
3 may further increase after publication of the revised
USPSTF guidelines. The revised guidelines did not
address mammography use for older women or women
with comorbid illnesses, so the analysis in Table 2
should not be affected.
Recommendations for breast cancer screening in the
hypothetical case vignettes varied little across physician
specialties based on the chronological age of patients;
h o w e v e r ,O B Gw e r es i g n i f i c a n t l ym o r el i k e l yt h a nI M
and FP to recommend mammography in patients with
limited life expectancy from coexisting comorbidities.
Similar to our findings, previous studies have found that
age is more important than comorbidities in influencing
clinical decision-making [23,24].
These results may be explained in several ways. First,
mixed strategies tailored to individuals’ clinical charac-
teristics and values are difficult to communicate and
implement in public health practice. Second,
mammography is a covered Medicare (fee-for-service)
benefit [23] and is widely promoted, and accepted
regardless of life expectancy and comorbidity. Third,
physicians may anticipate that not recommending mam-
mography to patients may decrease patient satisfaction,
and increase potential liability, as reported previously
[25].
Our study results are based on self-reported beha-
viours, and are thus likely to overestimate attitudes and
clinical behaviours viewed as desirable in actual practice.
Compared to third wave respondents early respondents
were predominantly females compared to males, OBG
compared to FP, 25-54 years compared to > = 55 years
of age, reported seeing higher number of new patients,
and were < = 9 years in practice. These results are dif-
ferent than reported from previous research on the web,
postal and mixed surveys studies showing that male
p h y s i c i a n sa r em o r el i k e l yt or e s p o n dt os u r v e y st h a n
female physicians [26]. This finding may be due to spe-
cific circumstances of this study, as breast cancer is the
second leading cause of cancer in women in the US,
controversies around regarding mammography guide-
lines, and OBG perceive themselves as primary care pro-
viders for women.
Our data are limited by the use of physicians’ self
reported preferences at a single point in time rather
than measures of actual clinical decisions. One of the
main limitations of this study is the low response rate
(< 10%). This rate is not surprising given that response
rates to surveys have declined dramatically over time
due to proliferation of junk mail, rapid growth and
ease of large-scale physician surveys, and resulting
complaints as physicians feel “bombarded” with Inter-
net based surveys despite increasing demands on their
time [18]. We chose to sample PCPs from a technically
literate sampling frame thus extrapolation of the
results is limited as the respondents to our web-based
survey may not represent the general population of
PCPs [27]. Although initial response rate improved
with a higher incentive, ($20 versus $5); however it is
unlikely that sending additional email reminders or
higher incentive would change our study results, or
external validity [27]. Comparisons between early
respondents and late respondents suggested non-
response was associated with gender, physician speci-
alty, age, and number of years in practice. However,
the absence of any differences between early and late
respondents on questions related to perceived effec-
tiveness and mammography recommendations suggests
that nonresponse did not substantively bias our key
findings. Although we tried to explore the potential for
non-response bias, this method still may not capture
the true extent of non-response bias in our survey
results [18,19,28].
Yasmeen et al. BMC Health Services Research 2012, 12:32
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Page 8 of 10Although case vignettes provided some background,
for the physician respondent it was a hypothetical situa-
tion that does not reflect actual primary care practice, in
which physicians provide continuing care of patients
who have a variety of coexisting clinical issues. The
magnitude of the influence of these factors may be con-
siderably underestimated or overestimated with the use
of clinical case vignettes.
Strengths of this study include a nationally representa-
tive sample of primary care specialties.
This study examined complex factors, and the impor-
tance of the cognitive component in mammography
decision making-in particular in the face of uncertain
guidelines among younger and older patients with speci-
fic clinical profiles. One of the key findings of this study
is that primary care physicians’ perceptions of the effec-
tiveness of screening mammography is very important
in decision making than the scientific evidence behind a
guideline, additionally the presence of comorbidity, play
a minor role.
Conclusions
This study demonstrated high awareness of breast can-
cer screening in a geographically diverse sample of pri-
mary care physicians. However, knowledge gaps about
the risks and benefits of screening mammography in
younger and older women, including older women
with comorbidities, are evident. Policy interventions
that focus on potentially modifiable physician factors
and cultures of practice change within primary care
specialties are needed to reduce potential overuse of
screening mammography. Although we studied pri-
mary care physicians at a single point in time and this
survey reflects only the stated preferences of respon-
dents, not their actual practices. However, our findings
suggest that physicians’ beliefs and perceptions of
effectiveness influence their practice and recommenda-
tions for screening mammography. Differing prefer-
ences for clinical practice guidelines across specialties
suggest that tailoring education by physician specialty
m a yb em o r ee f f e c t i v ei nr e d u cing inter-specialty prac-
tice variation for screening mammography. Combina-
tions of age and comorbidities should be included in
refining guidelines for older women to help foster pro-
fessional consensus about when to encourage or dis-
courage mammography.
Additional material
Additional File 1: Association of physician characteristics and
effectiveness of screening mammography in reducing breast cancer
mortality in different age categories. The table shows the association
of primary care physician’s characteristics (race, gender, age, years in
practice, US region of practice, personal history of having had a
screening mammogram, personal history of breast cancer and family
history of breast cancer) and their perceived effectiveness of screening
mammography in reducing breast cancer mortality in women age 40-49,
50-69 and 70-89 years.
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